Medigen Vaccine Biologics Corporation 6547.TWO Stock
Medigen Vaccine Biologics Corporation Price Chart
Medigen Vaccine Biologics Corporation 6547.TWO Financial and Trading Overview
| Medigen Vaccine Biologics Corporation stock price | 50.8 TWD |
| Previous Close | 60.1 TWD |
| Open | 60.1 TWD |
| Bid | 61.5 TWD x 0 |
| Ask | 61.6 TWD x 0 |
| Day's Range | 60.1 - 62.2 TWD |
| 52 Week Range | 55.4 - 154.1 TWD |
| Volume | 2.16M TWD |
| Avg. Volume | 3.07M TWD |
| Market Cap | 20.17B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.53 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 155 TWD |
6547.TWO Valuation Measures
| Enterprise Value | 19.7B TWD |
| Trailing P/E | N/A |
| Forward P/E | 55.405403 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.0091267 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Medigen Vaccine Biologics Corporation Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -59.49% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 154.1 TWD |
| 52 Week Low | 55.4 TWD |
| 50-Day Moving Average | 62.57 TWD |
| 200-Day Moving Average | 74.91 TWD |
6547.TWO Share Statistics
| Avg. Volume (3 month) | 3.07M TWD |
| Avg. Daily Volume (10-Days) | 1.26M TWD |
| Shares Outstanding | 327.84M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 27.34% |
| % Held by Institutions | 5.15% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1482.8058:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 1.13 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -212602000 TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -4.54 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 15.34 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Medigen Vaccine Biologics Corporation
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 16, Hu Road |
| ZIP | 114 |
| Phone | 886 2 7745 0830 |
| Website | https://www.medigenvac.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccines and biologics in Taiwan and internationally. The company is developing enterovirus A71 vaccine, which is in Phase III clinical trial to treat enterovirus infection; influenza vaccine, which has completed Phase III clinical trial to treat influenza; dengue vaccine, which has completed Phase II clinical trial for the treatment of dengue fever; respiratory cell fusion virus (RSV) antibody, which is in Phase I clinical trial for the prevention of RSV infection; and COVID-19 vaccine, which is in Phase III clinical trial to prevent COVID-19- severe special infectious pneumonia. Medigen Vaccine Biologics Corporation was founded in 2012 and is based in Taipei, Taiwan. Medigen Vaccine Biologics Corporation is a subsidiary of Medigen Biotechnology Corp.
Q&A For Medigen Vaccine Biologics Corporation Stock
What is a current 6547.TWO stock price?
Medigen Vaccine Biologics Corporation 6547.TWO stock price today per share is 50.8 TWD.
How to purchase Medigen Vaccine Biologics Corporation stock?
You can buy 6547.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Medigen Vaccine Biologics Corporation?
The stock symbol or ticker of Medigen Vaccine Biologics Corporation is 6547.TWO.
Which industry does the Medigen Vaccine Biologics Corporation company belong to?
The Medigen Vaccine Biologics Corporation industry is Biotechnology.
How many shares does Medigen Vaccine Biologics Corporation have in circulation?
The max supply of Medigen Vaccine Biologics Corporation shares is 328.61M.
What is Medigen Vaccine Biologics Corporation Price to Earnings Ratio (PE Ratio)?
Medigen Vaccine Biologics Corporation PE Ratio is now.
What was Medigen Vaccine Biologics Corporation earnings per share over the trailing 12 months (TTM)?
Medigen Vaccine Biologics Corporation EPS is -3.53 TWD over the trailing 12 months.
Which sector does the Medigen Vaccine Biologics Corporation company belong to?
The Medigen Vaccine Biologics Corporation sector is Healthcare.